BNP Paribas Fortis Private Equity
Warandeberg 3, Brussels, 1000, Belgium
Overview
BNP Paribas Fortis is the bank for a changing world. A bank managed in all transparency, driven by values of responsibility, humanity, innovation and enthusiasm. BNP Paribas Fortis is a credit institution with headquarters at Montagne du Parc 3, 1000 Brussels. Its share capital is 9,375 billion Euros, of which 99.93% is held by BNP Paribas a credit institution with headquarters in Paris. BNP Paribas Fortis is managed by a Board of Directors, who represent the shareholders collectively. The Board of Directors determines the general policy and strategy of the bank, oversees the Executive Committees activities, appoints and dismisses Executive Committee members and oversees internal control. Within the overall framework set by the Board, the board delegates BNP Paribas Fortis banking activities to the Executive Committee. BNP Paribas Fortis is a bank that is responsible and socially committed. The environment, diversity, cultural support, sponsorship... Through various and concrete ways, they are dedicated to meeting their customers’ expectations and proud to demonstrate their values: responsible, human, innovative and enthusiastic. BNP Paribas Fortis is very ambitious in this area. They are dedicated in various ways, thanks to their private foundation - BNP Paribas Fortis Foundation – as well also through their sectoral policies, their environmental commitments, their diversity policy, their cultural support and their sponsorship policy. BNP Paribas Fortis was born from the merger of a number of strong financial companies, which since the 19th century have been essential pillars of Belgium's economic and social history. Their bank is firmly rooted in their society and has a tradition of genuine commitment through its services and support to the economy. At BNP Paribas Fortis, they offer their customers a full range of financial products and services. Every day, they help their customers, regardless of their profile, whether they are individuals, companies or public institutions. BNP Paribas Fortis, it’s expertise and tailored solutions. It’s an international network in almost 75 countries!
- Total investments
- 12
- Lead investments
- 1
- Investments · 12mo
- 2
- Active investors
- 8
Sector focus
- Association
- Banking
- Financial Services
Investment portfolio
- MRM Health
Participated · Series B · Sep 2025
MRM Health develops microbiome-based biotherapeutic products using its proprietary CORAL® platform to assemble and produce disease-specific microbial consortia. The company is advancing its lead program MH002 into clinical development for ulcerative colitis and the rare condition pouchitis, while running preclinical programs in other inflammatory indications and immuno-oncology. MRM Health recently completed a €55 million Series B in September 2025 led by Biocodex with participation from ATHOS, BNP Paribas Fortis Private Equity and existing investors SFPIM, AvH, OMX Venture, QBic and VIB. The €2.6 million VLAIO grant will fund a three-year collaborative research program with Belgian academic partners to generate mechanistic and clinical microbiome data and accelerate LBP candidate development toward clinical proof-of-concept. The company is headquartered in Ghent, Belgium and reports products in clinical stages.
- GoFluo
Participated · Equity · Aug 2025
GoFluo is an Antwerp-based apparel brand that created a fashion-forward category of reflective safety vests ('bodyglowers') and related accessories. Founder and CEO Julie Vets has grown the business to seven employees, selling 160,000 bodyglowers, achieving 30% growth and generating €2M in revenue last year. The brand is active in 15 countries through a network of 500 dealers and has retail partnerships including A.S. Adventure, Globetrotter, Marathon Sports and Title Nine. Its product range includes dog reflectors (doggyglower), which was featured by Oprah, and various accessories beyond bike gear. This autumn GoFluo will launch a running collection to enter the running and athleisure segment and broaden its addressable market to runners, dog owners and employers buying for commuting employees. The company plans to use the new funding to accelerate internationalization and diversify into new segments.
- Vaultspeed
Participated · Series A · Nov 2023
VaultSpeed provides an automated data transformation solution that combines automation templates, a data modeling GUI and a metadata repository to improve delivery and maintenance of cloud data warehouses and lakehouses. The company is led by CEO Piet De Windt and is based in Leuven, Belgium, with offices in London, Seattle, Leuven and Vilnius. VaultSpeed works with customers including HDI, Olympus, Eurocontrol and Bleckmann and has established strategic partnerships with Snowflake, Microsoft and Databricks. It also maintains a network of more than 30 service partners to serve clients globally. VaultSpeed raised $15.9M in a Series A and intends to use the funds to expand operations and broaden its business reach. Vaultspeed offers a data automation software platform that helps data managers accelerate and automate the entire lifecycle (design, build and maintain) of Data Vault implementations to centralize enterprise data and deliver real-time insights. The platform connects with most popular ELT/ETL tools, source and target technologies, and orchestration engines. Its customer base spans from the Department of Health of Santa Clara County in California across Europe to customers in Japan, including Olympus. Vaultspeed recently signed a global deal with Olympus to build regional and global data integration platforms and create faster, better integrated insights on SAP and non‑SAP data. The company intends to use the €3.6m Series A proceeds to continue expanding operations and to invest in its product.
- Aphea.Bio
Participated · Series C · Jul 2023
Aphea.bio specialises in developing microbial strains and biostimulant products that boost plant nutrient uptake. The company is certified as a B Corp and employs a team of over 50 scientists and specialists. New funding will be used to expand research facilities and to open a new pilot plant later this year. A partnership with the Bill & Melinda Gates Foundation will direct development of products for smallholder farmers in Sub-Saharan Africa and South Asia. Financially, Aphea.bio has raised just over €100 million since mid-2017, with the latest round contributing to that total. The company is based in Gent, Belgium. Aphea.Bio develops a new generation of agro-biologicals—biostimulants and biofungicides—by harnessing the plant microbiome and natural microbial biodiversity. The company uses an innovative discovery platform that combines proprietary technologies to analyze microbial collections and identify beneficial strains. Its products target reduced fertilizer application and control of fungal diseases in row crops such as maize and wheat. With the completion of its Series B to €18M, Aphea.Bio plans to advance its portfolio toward regulatory approval and first commercial launch. ECBF's equity investment will support development and commercialization efforts to substitute agricultural chemicals with biological alternatives. Aphea.Bio was founded in December 2016 as a spin-off of VIB, Ghent University and K.U. Leuven and is based in Gent, Belgium. Aphea.Bio develops next-generation biopesticides and biostimulants based on naturally-occurring microorganisms to increase crop yields and improve protection against fungal diseases. The company aims to provide farmers an alternative to chemical pesticides and to stimulate crop growth by promoting nutrient uptake. Development is focused on staple crops such as wheat, barley and maize to target European and global market opportunities. Aphea.Bio spun out of the Vlaams Instituut voor Biotechnologie (VIB) and draws on research contributions from Ghent University and KU Leuven. Headquartered in Ghent, Belgium, the startup raised €9.0M comprising a €7.7M Series A and a €1.3M R&D grant from VLAIO. Management says the financing positions the company to develop new agricultural products and to exploit the currently untapped microbial space.
- MobieTrain
Led · Equity · Oct 2022
MobieTrain offers a microlearning, gamified mobile app with short 5–10 minute modules designed for onboarding and ongoing training of frontline employees. The product uses microlearning, gamification, quizzes, personalization and built-in retention techniques the company says make knowledge transfer up to six times more effective. Clients use the software to improve sales and customer experience, diversify training, support organisational changes, and for safety instructions across sectors such as retail, logistics, hospitality and healthcare. Founded in 2015, the Belgian HR tech scale-up serves over a hundred organisations in thirty countries and lists customers including Decathlon, Emirates Post, Diesel and Proximus. The company has achieved triple-digit growth over the past year, with more than half of its revenue coming from international markets and having more than doubled turnover in 2021. MobieTrain plans to use new funding to accelerate expansion into Germany, France, the UK and other European growth markets, strengthen teams in Genk, Madrid, Milan and Amsterdam, and sustain product development and innovation. MobieTrain offers a gamified mobile microlearning platform with bite-sized, personalized learning tracks and built-in retention techniques designed for deskless and frontline workers. The product roadmap focuses on adding new gamified elements and leveraging algorithms and machine learning to deliver the right content to the right person at the right time. Founded in 2015, the company serves nearly 100,000 users in more than 20 countries and counts clients such as Atlas Copco, Decathlon, Deloitte, Proximus, Diesel, Hästens, and public bodies including the municipality of Antwerp and the Dutch police. During the pandemic MobieTrain quadrupled its revenue and doubled its customer base; currently 50% of revenue comes from outside Belgium. The company has partnerships with SAP SuccessFactors and Goodhabitz and was added to the SAP store to support international expansion. The new funding will be used to further develop the platform, accelerate international growth, and grow the team from 25 to 40 employees. MobieTrain builds a mobile microlearning platform that enables employers to create five- to ten-minute training and retraining courses employees can access on their phones. Its customers include retail brands Diesel, Proximus, Timberland and Vans. The company has around 20 paying customers across 13 countries and is opening a small office in Lisbon where some technical development already takes place. MobieTrain plans to expand in its home market and focus growth on Northwestern Europe while targeting the hospitality and care sectors. Management says it will use artificial intelligence increasingly to personalise learning trajectories. Financially, MobieTrain has just raised €1.8 million from a Limburg investment company, the Concentra Media Group and existing investors, with BNP Paribas Fortis and another major bank providing a loan on top of the capital.